The role of isoniazid dosage and NAT2 gene polymorphism in the treatment of tuberculous meningitis
BackgroundTuberculous meningitis (TBM) is a non-purulent inflammatory condition affecting the meninges and spinal membranes, caused by Mycobacterium tuberculosis (MTB) infection. This study seeks to explore the impact of varying INH dosages and NAT2 gene polymorphisms on TBM treatment, contributing...
Saved in:
Main Authors: | Yi Jian, Yuhang Bao, Fashuang Yang, Mei Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1535447/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tuberculous cardiac tamponade presenting as severe hypoxic hepatitis
by: Valdes Roberto Bollela, et al.
Published: (2016-11-01) -
Pharmacokinetic Analysis of an Isoniazid Suspension Among Spanish Children Under 6 Years of Age
by: Antoni Noguera-Julian, et al.
Published: (2025-01-01) -
NAT444 solution to the dial-up address occupation in NFV environment
by: Yongming YAN, et al.
Published: (2016-11-01) -
Haplotype tagging efficiency and tagSNP sets portability in worldwide populations in NAT2 gene
by: Audrey Sabbagh, et al.
Published: (2007-12-01) -
Statistical analysis plan for the LAST ACT clinical trial; a Leukotriene A4 hydrolase Stratified non-inferiority Trial of Adjunctive Corticosteroids for HIV-negative adults with Tuberculous meningitis [version 2; peer review: 2 approved, 1 approved with reservations]
by: Joseph Donovan, et al.
Published: (2025-02-01)